9th Annual Biomarkers Congress

Oncology: National Institutes of Health

Total Score People Score Events Score
81 72 42
Date Event Presentation Speakers
June 4, 2013 World Pharma Congress Organs-on-Chips for Predicting Drug Toxicity and Efficacy Danilo Tagle
May 31, 2013 ASCO Annual Meeting 2013 Special Session Worta McCaskill-Stevens
April 6, 2013 AACR Annual Meetings BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Deborah Morrison
The MICR Scientific Symposium: Why Are Aggressive Forms of Cancer More Common Among Certain Racial/Ethnic Groups? Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA, and A. William Blackstock, Wake Forest University School of Medicine, Winston-Salem, NC Curtis C. Harris
Lymphoid Malignancies Co-Chairpersons: Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom, and Louis M. Staudt, National Cancer Institute, Bethesda, MD Louis M. Staudt
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY W. Marston Linehan
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James H. DOROSHOW
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Louis M. Staudt
Immune Reconstitution Following Lymphodepleting Cancer Therapy: Does It Matter? Crystal L. Mackall, National Cancer Institute, Bethesda, MD Crystal Mackall
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Career-Development Lunch Sessions Cynthia E. Dunbar
Trainee Simultaneous Didactic Sessions Cynthia E. Dunbar
October 18, 2012 Chicago International Breast Course and The Society for the Advancement of Women's Imaging Annual Meeting Panel Discussion: Controversies in Managing High Risk Lesions with ARS Wei Yang
Inflammatory Breast Lesions Wei Yang
Triple Negative Breast Cancer: Imaging Characteristics Wei Yang
January 19, 2012 9th Annual Natural Supplements: An Evidence-Based Update Office of Dietary Supplement Research Centers Supplement Use in the Military Rebecca B. Costello
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Re-Imagining the Ideal Antitumor T Cell Nicholas P. Restifo
Translating Immune Responses Toward and Into the Clinic (Joint) | TLRs in Vaccine Development Robert Seder
May 20, 2010 Bioanalytical Challenges for Optimizing Protein Therapeutics The Mesothelin-CA125/MUC16 Interaction Mitchell Ho
May 20, 2010 Antibody Optimization Deimmunizing Non-Human Proteins Ira Pastan
Chairperson’s Remarks Ira Pastan
March 5, 2010 7th Annual Oncology Nursing Advanced Practice: Innovation through Practice Genomic Translation and Clinical Choices Kathleen Calzone
February 22, 2010 2010 PERSONALIZED MEDICINE PARTNERSHIPS CONFERENCE Alternative Partnering Models for Personalized Medicine Christopher Austin
February 11, 2010 Second Annual Conference The Sixth Vital Sign: What Every Oncologist Should Know About Molecular Oncology: Applications to Patient Care Tumor Genomics Carolyn C. Compton
January 21, 2010 7th Annual Natural Supplements: An Evidence-Based Update Update on NIH/ NCCAM Dietary Supplement Research Craig Hopp
A. Pediatric and Adolescent Depression / Anxiety Wendy Weber
B. Dietary Supplements Resources: Point of Care Answers for the Busy Clinician Rebecca B. Costello
B. Natural Supplements in Cold and Flu Wendy Weber
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Integrative Healthcare: Towards a Science of Personalized Medicine Wendy B. Smith
November 6, 2009 Translating Scientific Advances Into Clinical Care for Cancer Genitourinary Cancer W. Marston Linehan
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Towards a More Efficient Protein Biomarker Development Process Henry Rodriguez
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine Targeting Tumor Microenvironment Suresh Mohla
August 14, 2009 Global Genitourinary Oncology Angiography and Intra-arterial Chemotherapeutic Ardeshir R. Rastinehad
February 3, 2009 Cancer Health Disparities WORKSHOPS 1 and 2 Vickie Shavers
SPECIAL SESSION: SECONDARY DATA ANALYSIS OF NATIONAL AND STATE HEALTH SURVEY DATA: ACCESS, ANALYSIS, AND FUNDING Richard P Moser, Amy Lazarus Yaroch
PLENARY SESSION 5: THE SCIENCE BEHIND CERVICAL CANCER DISPARITIES Philip E Castle
January 26, 2009 Translational Cancer Medicine BETTER in vivo MODELS : Mouse Cancer Models in Translation: Past, Present and Future Glenn Merlino
January 21, 2009 Advances in Prostate Cancer Research FORUM ON BIOMARKERS BEYOND PSA Sudhir Srivastava
January 5, 2009 High Content Analysis Multiparametric Flow Cytometry Analysis of Immune Responses for Vaccine Development Mario Roederer
Application of Quantitative High-Throughput Screening to High-Content Analysis of Cell-Based Assays Sunita J Shukla
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Identification of Novel Modifier Genes of Sox10 Neurocristopathy by a Functional Genomic approach : Track 1-3 Ling Hou
Application of Advanced Technologies to Personalized Oncology: Track 1-7 Francis S Collins
Biological Comparison of Human Anti-AMA1 IgGs :Track 2-9 Kazutoyo Miura
Development of Lentiviral Vectors for Studying on Gene Function, Gene Discovery and Gene Therapy :Track 2-12 Zhennan , Lai
November 23, 2008 Advanced Technology in Radiation Oncology Phase I Trial Of CC-5013 (Lenalidomide) In Pediatric Patients With Recurrent Or Refractory Primary CNS Tumors. Katherine Warren
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Introduction John A. , Milner
Dietary Supplements for Cancer Prevention: How Common and How Useful? Paul Coates
Split Session C: Diet, Supplements and UV Exposure: Defining Optimal Status of Vitamin D and How to Obtain It Mary Frances Picciano
Split Session D: Introduction Johanna T. Dwyer
Split Session D: Interventions to Lower Breast Cancer Risk: Domestic Perspectives Tanya Agurs-Collins
October 30, 2008 44th ASCO Annual Meeting General Session II: Identifying Patients for EGFR Inhibitor Therapy: Markers of Response and Resistance Tracy G Lively
Organizing Commitee Tracy G Lively, Milburn Jessup
Scientific Commitee Janet Dancey, Michael Birrer, Lalitha Shankar, Kevin Dobbin
September 29, 2008 Genomic Biomarkers Biomarkers for What? Diagnostic, Prognostic or Predictive? Sudhir Srivastava
September 19, 2008 Clinical Trials Workshop Planning Committee Andrea Denicoff
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty James Doroshow, Giuseppe Giaccone
Panel Discussion Jeffrey S Abrams
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
developmental therapeutics-- DNA Repair Modulators Yves Pommier
genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber
tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
April 27, 2008 Phage Display of Antibodies and Peptides Luncheon Workshop SlonoMax™ - A New Quality Level in Tailoring Genetic Diversity Thomas A Waldmann
March 25, 2008 R&D Risk Mitigation Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
March 25, 2008 Clinical Trials Asia Best Practices for Engaging Regulatory Authorities in Asia Sudhir Srivastava
March 25, 2008 Preclinical Development Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 25, 2008 TRANSLATIONAL MEDICINE The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
RNA Amplification as an Essential Approach for Biomarker Discovery Ena Wang
Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SESSION A: GRANT WRITING AND INTERNATIONAL FUNDING SOURCES Suresh Mohla
Grant Writing and Funding Opportunities at the NCI Suresh Mohla
A Rose between Two Thorns: Selecting the Right Journal Margaret A. Tucker
Title to be announced Michael Birrer
Molecular Profiling of Cancer: Challenges and Opportunities Paul Meltzer
The Promise of Genome-wide Association Studies Margaret A. Tucker
November 29, 2007 Fourth Annual In Vivo Molecular Imaging: Bridging the Gap from Discovery to Clinical Applications Nov (29-30) Imaging Tools - Novel Developments (08:25-13:40) Jacek Capala
Imaging Tools - Novel Developments: A New Molecular Tracer for In Vivo Monitoring of HER2 Expression by Positron Emission Tomography (08:30-09:00) Jacek Capala
Clinical Applications (13:40-17:30) Hisataka Kobayashi
Clinical Applications: Multiplexing Probes for in vivo Molecular Imaging (14:15-14:45) Hisataka Kobayashi
November 15, 2007 2007 Fourth International Conference 1. Integrative Oncology Education Models Panel Patrick J. Mansky
1. Integrative Oncology Education Models Panel Patrick J. Mansky
November 6, 2007 Chemotherapy Foundation Symposium XXV REGIONAL TREATMENT STRATEGIES FOR PATIENTS WITH HEPATIC METASTASES FROM MELANOMA James , Pingpank
October 20, 2007 Fourth Annual Fall Oncology Conference Future Directions of Lung Cancer Giuseppe Giaccone
October 11, 2007 Sixth International Colorectal Cancer Congress Inhibition of Hepatocyte Growth Factor and the c-Met Receptor John J. Wright
PI3K Inhibitors John J. Wright
September 25, 2007 Bioforum 2007 HEALTH : STATE OF RESEARCH AND PERSPECTIVES OF VACCINES IN ONCOLOGY ( 2:15 PM - 3:25 PM) Riccardo Dolcetti
Health: DISCUSSION AND CONCLUSION Riccardo Dolcetti
Health: IDIOTYPIC VACCINATION FOR B CELL LYMPHOPROLIFERATIONS: TOWARDS CLINICAL BENEFITS? Riccardo Dolcetti
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.